Steve N. Slilaty

Insider Reports History

Entity
Individual
Location
579 Rue Lajeunesse, Laval, Quebec, Canada
Signature
/s/ Steve N. Slilaty
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve N. Slilaty:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sunshine Biopharma, Inc Chief Executive Officer, Director, 10%+ Owner Series B Preferred Stock 130K $13K $0.10 Mar 4, 2024 Direct

Insider Reports Filed by Steve N. Slilaty

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SBFM Sunshine Biopharma, Inc Mar 4, 2024 1 $10K 4 Mar 5, 2024 Chief Executive Officer, Director, 10%+ Owner
SBFM Sunshine Biopharma, Inc Feb 8, 2024 1 $2K 4 Feb 12, 2024 Chief Executive Officer, Director, 10%+ Owner
SBFM Sunshine Biopharma, Inc Feb 18, 2022 1 -$99K 4 Feb 22, 2022 Chief Executive Officer, Director